Adults 45 to 75, male only, with Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Blood PressurePrimary· 8 weeks
Systolic blood pressure and diastolic blood pressure.
Systolic blood pressure
Group
Value
95% CI
Blueberry
125.6
± 2.5
Placebo
126.0
± 2.5
Diastolic blood pressure
Group
Value
95% CI
Blueberry
74.6
± 1.0
Placebo
75.1
± 1.0
Hemoglobin A1CSecondary· 8 weeks
Hemoglobin A1C is a surrogate marker of glycemic control over the preceding 2-3 months.
Group
Value
95% CI
Blueberry
7.1
± 0.1
Placebo
7.5
± 0.2
Sponsor's own description
Lifestyle strategies that include dietary modification, such as consumption of a plant-based diet, are well recognized in disease prevention and may improve type 2 diabetes. Various components of a plant-based diet may contribute to its beneficial health effects, but there has been keen interest in the possibility that plant polyphenols may have a role. Blueberries are dietary sources of polyphenols, specifically anthocyanins. To date there are few human clinical trials evaluating the beneficial health effects of blueberries in populations with type 2 diabetes. The objective of the study is to determine if freeze-dried blueberries compared to a blueberry placebo will improve cardiometabolic parameters in men with type 2 diabetes.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Albany Research Institute, Inc.
Last refreshed: 19 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02972996.